Omni Peptides

Wolverine Blend

Dhs. 400.00 AED

Sale Sold out

VIAL

Freeze-dried powder in a sealed glass vial. Reconstitute with bacteriostatic water and administer via syringe. The most versatile and cost-effective research format.

RECONSTITUTION & SYRINGE REQUIRED

CARTRIDGE

Pre-filled and ready to administer. Slides into a reusable pen injector — no measuring or mixing required. Clean, discreet, and consistent across research protocols.

REQUIRES COMPATIBLE PEN INJECTOR

NASAL

Delivered via mucosal absorption — no needles required. A popular choice for research protocols where needle-free administration is preferred.

NEEDLE-FREE — SPRAY & GO

PEN

An all-in-one auto-injector with the cartridge pre-loaded. Dial, click, and administer. Optimal for high-frequency research protocols requiring precise, repeatable dosing.

DIAL, CLICK & INJECT — NO PREP

Vials are freeze-dried (lyophilised) powder — kept refrigerated unopened, they remain stable for up to 2 years.

Cartridges, nasal sprays, and pens arrive pre-filled as liquid, must be kept refrigerated at all times, and carry a Beyond Use Date — typically 4–8 weeks from receipt. Please refer to the BUD on the label.

Size 10 mg (5+5) 20 mg (10+10)

Wolverine Blend (also known as the Wolverine Stack or BPC-157/TB-500 Blend) is a synthetic peptide combination consisting of BPC-157 (Body Protection Compound-157) and TB-500 (Thymosin Beta-4), typically formulated in a single vial (e.g., 10mg BPC-157 + 10mg TB-500 or similar ratios). This research formulation has gained significant attention in preclinical and regenerative medicine investigations for its synergistic potential to accelerate tissue repair, reduce inflammation, and support recovery processes. The nickname "Wolverine" draws from the Marvel character's rapid healing abilities, reflecting the observed complementary actions of the two peptides in animal models. Preliminary and advanced preclinical studies on the individual components and their combination suggest enhanced effects on angiogenesis, cell migration, extracellular matrix remodeling, and anti-inflammatory pathways. Researchers utilize Wolverine Blend in laboratory and animal models to explore mechanisms of musculoskeletal, soft tissue, and systemic regeneration, particularly in injury, overuse, and age-related degeneration contexts. As a research-grade compound, Wolverine Blend is intended exclusively for in vitro and animal studies. Scientists value its combined profile, which may offer broader regenerative coverage than either peptide alone, providing insights into multi-pathway peptide synergy in tissue restoration.

Composition

BPC-157C₆₂H₉₈N₁₆O₂₂·1419.5 g/mol

TB-500C₂₁₂H₃₅₀N₅₆O₇₈S·4963.5 g/mol

Molecular Weight

Composite (varies by exact ratio; typically ~6,383 g/mol for equal parts).

Sequences

BPC-157Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val

TB-500Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser

Research Applications

Musculoskeletal and Soft Tissue Regeneration
Preclinical models demonstrate that the BPC-157/TB-500 combination markedly accelerates healing of muscles, tendons, ligaments, and joints. It enhances biomechanical recovery, collagen organization, and structural integrity in transection, crush, and overuse injury models, often showing superior outcomes compared to single-peptide administration.
Injury Recovery and Wound Healing
Investigations highlight accelerated closure of cutaneous, surgical, and deep-tissue wounds, with reduced scar formation and improved granulation tissue quality. The blend supports re-epithelialization, cell proliferation, and resolution of inflammation in various trauma and post-surgical paradigms.
Anti-Inflammatory and Cytoprotective Effects
The combination potently downregulates pro-inflammatory cytokines, mitigates oxidative stress, and promotes a reparative microenvironment. Studies explore its efficacy in models of chronic inflammation, tendonitis, arthritis, and systemic inflammatory insults.
Angiogenesis and Vascular Support
Synergistic activation of VEGF pathways, endothelial cell migration, and new vessel formation facilitates nutrient delivery and oxygenation in ischemic or poorly vascularized tissues, enhancing overall regenerative potential.
Broader Systemic and Protective Effects
Research suggests benefits in gastrointestinal protection (from BPC-157's gastric origin), cardiac tissue support, and general recovery from physical stress. Emerging data probe its role in age-related decline, overuse syndromes, and multi-tissue repair scenarios.

Storage & Handling

Lyophilised vials are stable at −20°C for up to 2 years unopened. Once reconstituted, refrigerate at 2–8°C and use within 28 days. Avoid repeated freeze-thaw cycles.

Beyond Use Date

Pre-filled formats (cartridge, pen, nasal) carry a beyond-use date of typically 4–8 weeks from receipt. ≥98% purity by HPLC. For in vitro and preclinical research use only — not for human or veterinary use.